> If we can get approvals rolling faster without compromising safety, it might mean being able to release variant-specific boosters earlier in their transmission cycle.

This is basically it. We'd need an approval process similar to what exists for flu shots today. I'm not versed on what that process is, but if that can happen with covid, it'll be the biggest batch of red tape cut.